BUFFALO, NY — Sen. Kirsten Gillibrand visited Roswell Park Cancer Institute (RPCI) July 6, touring its Microarray and Genomics Core Laboratory and hearing from researchers who have created spinoff companies that are contributing to the Western New York economy.
“I just want to commend you for the extraordinary work and commitment that you’ve made not only to curing cancer but to working in Buffalo,” Sen. Gillibrand told the RPCI entrepreneurs. “It makes an enormous difference for our local communities and for New York State.”
Sen. Gillibrand met with RPCI administrators and researchers including Donald L. Trump, MD, FACP, President and CEO; Candace Johnson, PhD, Deputy Director; and Irwin Gelman, PhD, Chair, Department of Genetics; as well as several members of the RPCI Board of Directors.
Taking part in the discussion on technology entrepreneurship and business development were:
The mission of Roswell Park Cancer Institute (RPCI) is to understand, prevent and cure cancer. RPCI, founded in 1898, was one of the first cancer centers in the country to be named a National Cancer Institute-designated comprehensive cancer center and remains the only facility with this designation in Upstate New York. The Institute is a member of the prestigious National Comprehensive Cancer Network, an alliance of the nation’s leading cancer centers; maintains affiliate sites; and is a partner in national and international collaborative programs. For more information, visit RPCI’s website at http://www.roswellpark.org, call 1-877-ASK-RPCI (1-877-275-7724) or email email@example.com.
Annie Deck-Miller, Senior Media Relations Manager